Eli Lilly initiates phase III trial with selpercatinib in RET-mutant medullary thyroid cancer Dec. 30, 2019
Wave reports topline data from ongoing phase Ib/IIa study of WVE-120102 for Huntington's disease Dec. 30, 2019
FDA approves Lynparza as first-line maintenance treatment for gBRCAm metastatic pancreatic cancer Dec. 30, 2019
RSS